Overview
This study evaluates the impact of the hybrid closed-loop insulin delivery systems on sleep in youth with type 1 diabetes and their parents. Activity watches, surveys and device downloads are used to evaluate sleep in these participants.
Description
Sleep is important for everyone, including youth with type 1 diabetes. New technology has shown improvements in glycemic variability, especially overnight. This study evaluates the impact of advanced hybrid closed-loop insulin delivery systems on sleep for both youth with type 1 diabetes and their parents. Study measures include wearing an actigraphy watch and completing a sleep diary for 7 days and taking surveys on sleep and psychosocial measures. Study measures occur prior to starting the hybrid closed-loop system, immediately after starting the system and at 3 and 6 months after starting the system.
Eligibility
Inclusion Criteria:
- Child diagnosed with type 1 diabetes for at least 3 months
- Child receives clinical care at the Barbara Davis Center for Diabetes
- Child starting an advanced HCL system as part of routine diabetes care
- Child currently living with a parent who is willing to complete surveys for this study
- Family able to read and speak English
- Parent lives at home with the child with type 1 diabetes
- Parent able to read and speak English
Exclusion Criteria:
- Child has an active underlying sleep disorder, such as narcolepsy, insomnia or untreated sleep apnea
- Child participating in an interventional research protocol
- Child unable to complete study procedures
- Parent has an active underlying sleep disorder, such as narcolepsy, insomnia or untreated sleep apnea
- Parent unable to complete study procedures